David T Yang
Affiliation: University of Wisconsin
- Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphomaDavid T Yang
Department of Pharmacology, University of Wisconsin School of Medicine and Public Health, Madison, USA
Mol Cancer 7:40. 2008..While MCL cells have been shown to harbor constitutive NF-kappaB activity, what fraction of this activity in primary MCL samples is sensitive or resistant to inhibition by bortezomib remains unclear...
- Use of tissue microarray and automated quantitative analysis for screening and validation of potential biomarkers in mantle cell lymphomaDavid T Yang
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, USA
Appl Immunohistochem Mol Morphol 19:62-9. 2011....
- Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancerAnne M Traynor
Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Lung Cancer 81:138-41. 2013..We sought to determine if protein expression of nEGFR is prognostic in early stage non-small cell lung cancer (NSCLC)...
- VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network studyJulie E Chang
Department of Medicine, School of Medicine and Public Health, The UW Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA
Br J Haematol 155:190-7. 2011..The observed 3-year PFS and OS with VcR-CVAD in MCL were comparable to reported outcomes with more intensive regimens. A cooperative group trial (E1405) is attempting to replicate these promising results...